VA - (3.5 Mos. Post-Separation) | |||||||
Code | Rating | Condition | Code | Rating | Exam | ||
Asthma | 6602 | 10% | Asthma | 6602 | 10% * | 200 20504 | |
Hyperlipidemia | Category III | No VA Entry | |||||
Tobacco Habituation | Category III | ||||||
Episodic Low Back Pain | 5299-5295 | 10% | 20020504 | ||||
0% X 1/ Not Service-Connected x 2 | 20020504 20020427 |
||||||
Combined: 20% |
Pulmonary Exam | MEB ~5 Mo. Pre-Sep (20010830) |
VA ~3.5 Mo. Post-Sep |
FEV1 (% Predicted) | pre-treatment 69% post-treatment 82% |
Pre drug 72% Post drug 77% |
FEV1/FVC | pre-treatment 76% post-treatment 80% |
pre-treatment 74% post-treatment 80% |
Meds | Azmacort bid, albuterol prn | Azmacort qid, albuterol prn |
§4.97 Rating | 30% | 30% |
UNFITTING CONDITION | VASRD CODE | RATING |
Asthma | 6602 | 30% |
COMBINED | 30% |
AF | PDBR | CY2012 | PD 2012 00671
(2) is limited to those conditions which were determined by the PEB to be specifically unfitting for continued military service; or, when requested by the CI, those condition(s) identified but not determined to be unfitting by the PEB. The ratings for unfitting conditions will be reviewed in all cases. Asthma. The PEB and VA both rated the asthma condition 10% code 6602, asthma.
AF | PDBR | CY2013 | PD-2013-01970
RATING COMPARISON : Service IPEB – Dated 20050708VA -(7 Mos. Physical Disability Board of Review I have carefully reviewed the evidence of record and the recommendation of the Board.
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2013 | PD2013 00352
SEPARATION DATE: 20050114 It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified, but not determined to be unfitting by the PEB when specifically requested by the CI. The Board noted that the NARSUM and multiple entries found in the service treatment record, months prior to separation, documented that daily use of inhaled anti-inflammatory medication (Advair, Azmacort or Flovent)and daily inhalational...
AF | PDBR | CY2012 | PD2012 01083
He was issued a permanent P3 profile andreferred for a Medical Evaluation Board (MEB).Asthma and mild restrictive pattern were forwarded to the Physical Evaluation Board (PEB) as medically unacceptable IAW AR 40-501.The PEB adjudicated the asthma and mild restrictive pattern as unfitting, rated 10% with application of the Veteran’s Affairs Schedule for Rating Disabilities (VASRD).The CI made no appeals, and was medically separated with a 10% disability rating. a month prior to the PEB,...
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2014 | PD-2014-03334
RECORD OF PROCEEDINGSPHYSICAL DISABILITY BOARD OF REVIEWNAME: XXXXXXXXXXXXXXXXXX CASE: PD-2014-03334BRANCH OF SERVICE: AIR FORCEBOARD DATE: 20141209 On a Health History form dated 27 December 2004 (2 months prior to separation);the CI indicated that he was using albuterol for asthma; no other medications were listed.On the Report of Medical Assessment dated 25 January 2005 (a month prior to separation) the CI listed Albuterol as the only medication he was using for asthma.During the VA...
AF | PDBR | CY2013 | PD-2013-01940
Asthma Condition . The examiner concluded that the CI was “doing well with daily Flovent use.” The plan was to continue using Flovent twice per day.The narrative summaryon 30 March 2005 (4 months prior to separation) reported that the CI had not required systemic steroids or emergency treatment. BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent...
AF | PDBR | CY2014 | PD-2014-00018
Separation Date: 20060127 The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the VASRD standards to the unfitting medical condition at the time of separation. Accordingly, the Board recommended your separation be re-characterized to reflect disability retirement, rather than separation with severance pay.I have carefully reviewed the evidence of record and the recommendation of the Board.
AF | PDBR | CY2014 | PD-2014-01508
Separation Date: 20081230 The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVeterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. The examiner documented that the CI was actively taking all prescribed medications.